Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Core EBITDA Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 75.89-27.6568.7394.61-11.18

What is the latest Core EBITDA Growth ratio of NEULAND LABORATORIES ?

The latest Core EBITDA Growth ratio of NEULAND LABORATORIES is 75.89 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202675.89
Mar2025-27.65
Mar202468.73
Mar202394.61
Mar2022-11.18

How is Core EBITDA Growth of NEULAND LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 75.89
Positive
Mar2025 -27.65
Negative
Mar2024 68.73
-27.35
Mar2023 94.61
Positive
Mar2022 -11.18 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Core EBITDA Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹29,728.5 Cr 1.3% 20.9% 69.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

1.3%

20.9%

69.4%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses